SERA PROGNOSTICS, INC. Interest Payable, Current
SERA PROGNOSTICS, INC. (SERA) had Interest Payable, Current of $0 as of 2021-12-31, per its 10-K filed 2022-03-29.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2022-03-29
- 2021-12-31: Interest Payable, Current $0.00.
- 2021-09-30: Interest Payable, Current $0.00.
- 2021-06-30: Interest Payable, Current $0.00.
- 2020-12-31: Interest Payable, Current $996.00K.
| Period end | Interest Payable, Current |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-29 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-30 |
| 2020-12-31 | $996.00K 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |